One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Screening Strategies for Identification of Transthyretin Amyloid Cardiomyopathy
doi : 10.1016/j.jchf.2026.103018
Volume 14, Issue 5, May 2026, 103018
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF Trial
doi : 10.1016/j.jchf.2025.102778
Volume 14, Issue 5, May 2026, 102778
Navigating the Intersection of HFmrEF/HFpEF and CKD: High-Risk With Gaps in Evidence
doi : 10.1016/j.jchf.2026.102941
Volume 14, Issue 5, May 2026, 102941
Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into Action
doi : 10.1016/j.jchf.2025.102849
Volume 14, Issue 5, May 2026, 102849
From Signals to Decisions: The Need for Standardized Reporting in Heart Failure Remote Monitoring
doi : 10.1016/j.jchf.2026.102950
Volume 14, Issue 5, May 2026, 102950
Severe Myocarditis Increase in Children Associated With Parvovirus B19 Infection: MYKKE Registry and German Surveillance Data
doi : 10.1016/j.jchf.2025.102854
Volume 14, Issue 5, May 2026, 102854
Parvovirus B19 in Pediatric Myocarditis: When Context Becomes Clinical Action
doi : 10.1016/j.jchf.2026.102953
Volume 14, Issue 5, May 2026, 102953
Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF
doi : 10.1016/j.jchf.2025.102900
Volume 14, Issue 5, May 2026, 102900
Lactate Dehydrogenase as a Systemic Biomarker: Revisiting an Old Marker for Heart Failure
doi : 10.1016/j.jchf.2026.102954
Volume 14, Issue 5, May 2026, 102954
Rising Exception Requests in the Current Heart Allocation System
doi : 10.1016/j.jchf.2025.102776
Volume 14, Issue 5, May 2026, 102776
When the Exception Becomes the Rule: Rethinking Heart Allocation in the Era of Status Inflation
doi : 10.1016/j.jchf.2025.102833
Volume 14, Issue 5, May 2026, 102833
So Your Patient Wants Stem Cells
doi : 10.1016/j.jchf.2026.103002
Volume 14, Issue 5, May 2026, 103002
Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial
doi : 10.1016/j.jchf.2025.102780
Volume 14, Issue 5, May 2026, 102780
Lipoprotein(a) and Outcomes in Worsening Heart Failure With Preserved Ejection Fraction: The PARAGLIDE-HF Trial
doi : 10.1016/j.jchf.2025.102843
Volume 14, Issue 5, May 2026, 102843
App-Based Coaching Improves Physical Activity in Patients With HFpEF: Results of the MyoMobile Trial
doi : 10.1016/j.jchf.2025.102845
Volume 14, Issue 5, May 2026, 102845
Heart Failure With Preserved Ejection Fraction and Microvascular Disease Using Retinal Optical Coherence Tomography Angiography
doi : 10.1016/j.jchf.2025.102846
Volume 14, Issue 5, May 2026, 102846
Artificial Intelligence to Extract Structured Details From Unstructured Medical Records in a Global Heart Failure Trial
doi : 10.1016/j.jchf.2025.102851
Volume 14, Issue 5, May 2026, 102851
Heart Replacement Therapy: Are We Following the Right Direction?
doi : 10.1016/j.jchf.2026.103053
Volume 14, Issue 5, May 2026, 103053
